The US-based drug maker Amgen has set up a new technology and innovation centre in Hyderabad and is planning to invest $200 million through 2025, with additional sustained investments planned over the coming years.
“I welcome Amgen to our vibrant city, as they work toward making a difference in patients’ lives around the world. We look forward to working with global leaders such as Amgen to strengthen Hyderabad’s position as a biotech hub,” Chief Minister A Revanth Reddy after while formally inaugurating the centre in Hitec city here on Monday.
The site will accelerate Amgen’s digital capabilities through artificial intelligence and data science to further advance its pipeline of medicines, while creating significant opportunities for local talent.
“The opening of Amgen India marks a significant milestone in our endeavour to leverage technology across our global network to better serve patients,” Robert A. Bradway, Chairman and Chief Executive Officer at Amgen said.
“We are grateful to the Government of Telangana for its partnership and are proud to join an ecosystem where life sciences and cutting-edge innovation can thrive,’‘ he added.
“Amgen India is a reflection of our growth ambitions as well as an extension of our commitment to global health,” said Som Chattopadhyay, National Executive for India at Amgen. “We are excited to contribute to the dynamic global biotech ecosystem from India and welcome the incredible talent pool the country offers, ‘‘ he added.
Under the leadership of the global organisation, Amgen India will play a pivotal role in advancing innovation by developing and deploying technology and life sciences solutions to accelerate Amgen’s digital capabilities worldwide, the company said.